Search by Drug Name or NDC
NDC 59627-0333-04 AVONEX Details
AVONEX
AVONEX is a INTRAMUSCULAR KIT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Biogen Inc.. The primary component is .
MedlinePlus Drug Summary
Interferon beta-1a intramuscular injection is used to treat adults with various forms of multiple sclerosis (MS; a disease in which the nerves do not function properly and people may experience weakness, numbness, loss of muscle coordination, and problems with vision, speech, and bladder control) including: clinically isolated syndrome (CIS; nerve symptom episodes that last at least 24 hours), relapsing-remitting forms (course of disease where symptoms flare up from time to time), or secondary progressive forms (course of disease where relapses occur more often). Interferon beta-1a is in a class of medications called immunomodulators. It works by decreasing inflammation and preventing nerve damage that may cause symptoms of multiple sclerosis.
Related Packages: 59627-0333-04Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Interferon Beta-1a Intramuscular Injection
Interferon beta-1a subcutaneous injection is used to treat adults with various forms of multiple sclerosis (MS; a disease in which the nerves do not function properly and people may experience weakness, numbness, loss of muscle coordination, and problems with vision, speech, and bladder control) including: clinically isolated syndrome (CIS; nerve symptom episodes that last at least 24 hours), relapsing-remitting forms (course of disease where symptoms flare up from time to time), or secondary progressive forms (course of disease where relapses occur more often). Interferon beta-1a is in a class of medications called immunomodulators. It works by decreasing inflammation and preventing nerve damage that may cause symptoms of multiple sclerosis.
Related Packages: 59627-0333-04Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Interferon Beta-1a Subcutaneous Injection
Product Information
NDC | 59627-0333 |
---|---|
Product ID | 59627-333_3ff19956-a793-4256-bff4-7f7443d7238a |
Associated GPIs | 6240306045F530 |
GCN Sequence Number | 067628 |
GCN Sequence Number Description | interferon beta-1a PEN IJ KIT 30MCG/.5ML INTRAMUSC |
HIC3 | H0E |
HIC3 Description | AGENTS TO TREAT MULTIPLE SCLEROSIS |
GCN | 30222 |
HICL Sequence Number | 011253 |
HICL Sequence Number Description | INTERFERON BETA-1A |
Brand/Generic | Brand |
Proprietary Name | AVONEX |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | interferon beta-1a |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | KIT |
Route | INTRAMUSCULAR |
Active Ingredient Strength | n/a |
Active Ingredient Units | n/a |
Substance Name | n/a |
Labeler Name | Biogen Inc. |
Pharmaceutical Class | n/a |
DEA Schedule | n/a |
Marketing Category | BLA |
Application Number | BLA103628 |
Listing Certified Through | 2024-12-31 |
Package
NDC 59627-0333-04 (59627033304)
NDC Package Code | 59627-333-04 |
---|---|
Billing NDC | 59627033304 |
Package | 1 KIT in 1 CARTON (59627-333-04) * 1 SYRINGE in 1 BOX / .5 mL in 1 SYRINGE * 4 POUCH in 1 POUCH / .4 mL in 1 POUCH |
Marketing Start Date | 2014-08-29 |
NDC Exclude Flag | N |
Pricing Information | |
Price Per Unit | 8024.79 |
Pricing Unit | EA |
Effective Date | 2024-01-01 |
NDC Description | AVONEX PEN 30 MCG/0.5 ML KIT |
Pharmacy Type Indicator | C/I |
OTC | N |
Explanation Code | 4, 5 |
Classification for Rate Setting | B |
As of Date | 2024-02-21 |